The purpose of the study is to evaluate the efficacy and safety of acetaminophen and aspirin versus placebo in the acute treatment of migraine
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
900
2 tablets each containing Acetaminophen 250 mg and Aspirin 250 mg
2 placebo tablets matching acetaminophen 250 mg and aspirin 250 mg tablets
Unnamed facility
Birmingham, Alabama, United States
Unnamed facility
Anaheim, California, United States
Unnamed facility
San Francisco, California, United States
Number of Subjects Who Are Pain Free at the 2-hour Assessment
Number of subjects who are pain free at the 2-hour assessment
Time frame: 2 hours
Number of Subjects Who Are Nausea Free at the 2-hour Assessment
Number of subjects who are nausea free at the 2-hour assessment
Time frame: 2 hours
Number of Subjects Who Are Free of Photophobia at the 2-hour Assessment.
Number of subjects who are free of photophobia at the 2-hour assessment.
Time frame: 2 hours
Number of Subjects Who Are Free of Phonophobia at the 2-hour Assessment.
Number of subjects who are free of phonophobia at the 2-hour assessment.
Time frame: 2 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Unnamed facility
Fort Lauderdale, Florida, United States
Unnamed facility
Jupiter, Florida, United States
Unnamed facility
Oviedo, Florida, United States
Unnamed facility
West Palm Beach, Florida, United States
Unnamed facility
Evansville, Indiana, United States
Unnamed facility
Ann Arbor, Michigan, United States
Unnamed facility
Berlin, New Jersey, United States
...and 9 more locations